Vanderbilt Evaluating GE Platform for Insights into Colon Cancer | GenomeWeb

NEW YORK (GenomeWeb News) – Vanderbilt University is partnering with GE Global Research to evaluate GE's cancer mapping technology for cellular insight into colon tumors.

The partnership, announced today and supported by a five-year, $3.75 million grant from the Office of the Director of the National Institutes of Health, will test GE's automated platform that can probe and analyze up to 60 different disease biomarkers, including proteins and messenger RNAs, in a single tissue sample.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.